Details
| Titel in Übersetzung | Costs of Urinary Incontinence in Germany |
|---|---|
| Originalsprache | Mehrere Sprachen |
| Seiten (von - bis) | 301-309 |
| Seitenumfang | 9 |
| Fachzeitschrift | Gesundheitsokonomie und Qualitatsmanagement |
| Jahrgang | 12 |
| Ausgabenummer | 5 |
| Frühes Online-Datum | 22 Okt. 2007 |
| Publikationsstatus | Veröffentlicht - Okt. 2007 |
Abstract
Aim: To investigate direct costs and quality of life of female patients suffering from urinary incontinence (UI) in Germany. Method: PURE (Prospective Urinary Incontinence Research) was a prospective, European wide non-interventional post marketing surveillance study over 6 months. Data were collected by investigators and patients at baseline, at two following visits after three and six months and also retrospectively for twelve month prior to baseline. Quality of life data was collected using the disease specific I-QoL and the generic EQ-5D. Data was analyzed with standard descriptive and analytical statistical methods. Data for Germany will be compared and discussed with respect to data collected in other European countries within the overall PURE study. Results: Data from 2715 female patients with a mean age of 66.3 years could be included into the analysis. Costs data within the paper are presented for different types of UI. A special focus will be given to differences in specific direct cost domains, age, income and other socio demographic variables. Conclusion: PURE allows an insight into the economic costs and consequences of urinary incontinence both in relation to national health care systems and in direct relation to the patient as both costs of the public sector and patients' treatment costs were analyzed. In a comparison between Germany, Spain and UK/Ireland, costs for conservative treatment were highest in UK/Ireland.
Schlagwörter
- Costs, Quality of life, Therapy, Urinary incontinence
ASJC Scopus Sachgebiete
- Medizin (insg.)
- Health policy
Ziele für nachhaltige Entwicklung
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: Gesundheitsokonomie und Qualitatsmanagement, Jahrgang 12, Nr. 5, 10.2007, S. 301-309.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Kosten der Harninkontinenz in Deutschland
AU - Graf Von Der Schulenburg, J. M.
AU - Mittendorf, T.
AU - Clouth, J.
AU - Stoeber, Y.
AU - Greiner, W.
PY - 2007/10
Y1 - 2007/10
N2 - Aim: To investigate direct costs and quality of life of female patients suffering from urinary incontinence (UI) in Germany. Method: PURE (Prospective Urinary Incontinence Research) was a prospective, European wide non-interventional post marketing surveillance study over 6 months. Data were collected by investigators and patients at baseline, at two following visits after three and six months and also retrospectively for twelve month prior to baseline. Quality of life data was collected using the disease specific I-QoL and the generic EQ-5D. Data was analyzed with standard descriptive and analytical statistical methods. Data for Germany will be compared and discussed with respect to data collected in other European countries within the overall PURE study. Results: Data from 2715 female patients with a mean age of 66.3 years could be included into the analysis. Costs data within the paper are presented for different types of UI. A special focus will be given to differences in specific direct cost domains, age, income and other socio demographic variables. Conclusion: PURE allows an insight into the economic costs and consequences of urinary incontinence both in relation to national health care systems and in direct relation to the patient as both costs of the public sector and patients' treatment costs were analyzed. In a comparison between Germany, Spain and UK/Ireland, costs for conservative treatment were highest in UK/Ireland.
AB - Aim: To investigate direct costs and quality of life of female patients suffering from urinary incontinence (UI) in Germany. Method: PURE (Prospective Urinary Incontinence Research) was a prospective, European wide non-interventional post marketing surveillance study over 6 months. Data were collected by investigators and patients at baseline, at two following visits after three and six months and also retrospectively for twelve month prior to baseline. Quality of life data was collected using the disease specific I-QoL and the generic EQ-5D. Data was analyzed with standard descriptive and analytical statistical methods. Data for Germany will be compared and discussed with respect to data collected in other European countries within the overall PURE study. Results: Data from 2715 female patients with a mean age of 66.3 years could be included into the analysis. Costs data within the paper are presented for different types of UI. A special focus will be given to differences in specific direct cost domains, age, income and other socio demographic variables. Conclusion: PURE allows an insight into the economic costs and consequences of urinary incontinence both in relation to national health care systems and in direct relation to the patient as both costs of the public sector and patients' treatment costs were analyzed. In a comparison between Germany, Spain and UK/Ireland, costs for conservative treatment were highest in UK/Ireland.
KW - Costs
KW - Quality of life
KW - Therapy
KW - Urinary incontinence
UR - http://www.scopus.com/inward/record.url?scp=36049001486&partnerID=8YFLogxK
U2 - 10.1055/s-2007-963204
DO - 10.1055/s-2007-963204
M3 - Article
AN - SCOPUS:36049001486
VL - 12
SP - 301
EP - 309
JO - Gesundheitsokonomie und Qualitatsmanagement
JF - Gesundheitsokonomie und Qualitatsmanagement
SN - 1432-2625
IS - 5
ER -